Pompe disease is a debilitating condition that results in abnormally high tissue glycogen concentrations and is the subject of significant therapeutic focus by the pharma industry, including promising gene therapies. Non-invasive biomarkers that are specific and sensitive are sought after to address major gaps in early phase clinical trials. We characterized 13C MRS measurements of muscle glycogen concentration as potential biomarkers in Pompe disease, including test/re-test measurements and correlation with tissue biochemical measurements. Strong specificity and reasonable reproducibility was found, suggesting potential for 13C MRS to be used in Pompe disease patients.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords